LONDON and CARLSBAD, Calif., Feb. 06, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that Justin Gover, GW’s Chief Executive Officer, will present at the Leerink Partners 7th Annual Global Healthcare […]

by

ISTOCK, CREATIVE-FAMILYChronic pain caused by cancer treatments or tumor cells growing in bone can be severe and debilitating. The lack of effective pain relief by prescription painkillers is leading many cancer patients to try alternative medicine, notably, marijuana. But despite the plant’s ever-expanding popularity, and a growing body of evidence to suggest it can help […]

by

LONDON and CARLSBAD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercialising novel therapeutics from its proprietary cannabinoid product platform, announced today that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for […]

by

Americans for Safe Access, a national medical marijuana patient advocacy group, on Thursday released a paper on the opioid crisis and how cannabis medicines can help break the addiction cycle in prescription pain medication abuse. The paper uses Michigan as a case study of the effectiveness of the state’s medical marijuana program in diminishing the deaths and […]

by

ISTOCK, CREATIVE-FAMILYChronic pain caused by cancer treatments or tumor cells growing in bone can be severe and debilitating. The lack of effective pain relief by prescription painkillers is leading many cancer patients to try alternative medicine, notably, marijuana. But despite the plant’s ever-expanding popularity, and a growing body of evidence to suggest it can help […]

by

LONDON and CARLSBAD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercialising novel therapeutics from its proprietary cannabinoid product platform, announced today that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for […]

by

AGENDA  MAPLE VALLEY CITY COUNCIL REGULAR BUSINESS (SPECIAL) MEETING   Monday, November 13, 2017                                                     Lake Wilderness Lodge 7:00 p.m.                                                                                           22500 SE 248th Street CALL TO ORDER FLAG SALUTE/ROLL CALL PUBLIC COMMENTS This is an opportunity for the public to address the Council on any subject, which is not of a quasi-judicial […]

by

Visit the Harvest One Cannabis Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors. Harvest One Cannabis Inc. – Favourable Results from Phase 2 Clinical Trials using Satipharm Capsules VANCOUVER, Feb. 1, 2018 /CNW/ – Harvest One Cannabis Inc. (TSXV: HVT) (“Harvest One” or the “Company”) through its […]

by

Visit the Harvest One Cannabis Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors. Harvest One Cannabis Inc. – Favourable Results from Phase 2 Clinical Trials using Satipharm Capsules VANCOUVER, Feb. 1, 2018 /CNW/ – Harvest One Cannabis Inc. (TSXV: HVT) (“Harvest One” or the “Company”) through its […]

by